Search PDMR transactions

Search

Publication date Issuer Person discharging managerial responsibilities Position Closely associated Nature of transaction Instrument name ISIN Transaction date Volume Unit Price Currency Trading venue Status
06/05/2018 NeuroVive Pharmaceutical AB David Olof Rikard Bejker Styrelseledamot/suppleant Subscription NeuroVive Pharmaceutical BTU SE0011089002 27/04/2018 3819 Quantity 8.00 SEK NASDAQ STOCKHOLM AB Details
25/04/2018 NeuroVive Pharmaceutical AB Erik Kinnman VD Subscription NeuroVive Pharmaceutical AB BTU SE0008241871 25/04/2018 8812 Quantity 8.00 SEK NASDAQ STOCKHOLM AB History Details
25/04/2018 NeuroVive Pharmaceutical AB Erik Kinnman VD Acquisition NeuroVive Pharmaceutical AB BTU SE0008241871 25/04/2018 8812 Quantity 8.00 SEK NASDAQ STOCKHOLM AB Revised Details
25/04/2018 NeuroVive Pharmaceutical AB Marcus Keep, Eskil Elmée and Michael Vickers Board Member, CSO and Chair Nomination in NeuroVive Yes Disposal Rights Issue Warrants 20/04/2018 11623296 Quantity 0.01 SEK Outside a trading venue History Details
25/04/2018 NeuroVive Pharmaceutical AB Marcus Keep, Eskil Elmée and Michael Vickers Board Member, CSO and Chair Nomination in NeuroVive Yes Disposal Rights Issue Warrants 20/04/2018 11623296 Quantity 0.11 SEK Outside a trading venue Revised Details
25/04/2018 NeuroVive Pharmaceutical AB Eskil Elmér Forskningschef Subscription NeuroVive Pharmaceutical BTU SE0011089002 24/04/2018 19407 Quantity 8.00 SEK NASDAQ STOCKHOLM AB Details
25/04/2018 NeuroVive Pharmaceutical AB Magnus Hansson Chief Medical Officer Allotment NeuroVive Pharmaceutical AB BTU SE0011089002 24/04/2018 20000 Quantity 8.00 SEK NASDAQ STOCKHOLM AB Details
25/04/2018 NeuroVive Pharmaceutical AB Eskil Elmér Forskningschef Disposal NeuroVive Pharmaceutical UR SE0011088996 20/04/2018 1060905 Quantity 0.01 SEK NASDAQ STOCKHOLM AB Details
23/02/2017 NeuroVive Pharmaceutical AB ERIK KINNMAN VD Acquisition NeuroVive Pharmaceutical AB SE0002575340 23/02/2017 8600 Quantity 5.62 SEK NASDAQ STOCKHOLM AB Details
23/02/2017 NeuroVive Pharmaceutical AB MAGNUS HANSSON Chief Medical Officer Acquisition NeuroVive Pharmaceutical AB SE0002575340 23/02/2017 10000 Quantity 5.65 SEK NASDAQ STOCKHOLM AB Details
Showing 1 to 10 of 13 result